{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:17:07Z","timestamp":1792603027416,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.waojou.2023.100795","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T04:56:54Z","timestamp":1689051414000},"page":"100795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Update meta-analysis on the efficacy and safety issues of fexofenadine"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6898-186X","authenticated-orcid":false,"given":"Ren\u00e9 Maximiliano","family":"G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Compalati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio Javier","family":"Ansotegui Zubeldia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.waojou.2023.100795_bib1","first-page":"S1081","article-title":"The shifting prevalence of asthma and allergic disease in United States children","author":"Pate","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100795_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2021-001004","article-title":"Asthma, rhinitis and eczema symptoms in Quito, Ecuador: a comparative cross-sectional study 16 years after ISAAC","volume":"8","author":"Cabrera","year":"2021","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"10.1016\/j.waojou.2023.100795_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13656","article-title":"Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: global Asthma Network Phase I","volume":"33","author":"Strachan","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2023.100795_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/pai.12022","article-title":"Allergic airway diseases in childhood - marching from epidemiology to novel concepts of prevention","volume":"23","author":"Hatzler","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100795_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1185\/0300799019117011","article-title":"The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare","volume":"17","author":"Hindmarch","year":"2001","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.waojou.2023.100795_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.0022-0477.2001.01245.x","article-title":"An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers","volume":"32","author":"Hindmarch","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2023.100795_bib7","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0149-2918(03)80137-6","volume":"25","author":"Ridout","year":"2003","journal-title":"Clin Therapeut"},{"issue":"1","key":"10.1016\/j.waojou.2023.100795_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000321896","article-title":"Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials","volume":"156","author":"Compalati","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100795_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40360-019-0363-1","article-title":"Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials","volume":"20","author":"Huang","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.waojou.2023.100795_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100658","article-title":"Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: a real-world evidence study and systematic review","volume":"15","author":"Carnovale","year":"2022","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.waojou.2023.100795_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.18176\/jiaci.0649","article-title":"Urtigal, the Galician group of interest in urticaria. Efficacy and safety of up-dosing antihistamines in chronic spontaneous urticaria: a systematic review of the literature","volume":"31","author":"Iriarte Sot\u00e9s","year":"2021","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"12","key":"10.1016\/j.waojou.2023.100795_bib12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/cea.13500","article-title":"Cardiac safety of second-generation H1 -antihistamines when updosed in chronic spontaneous urticaria","volume":"49","author":"Cataldi","year":"2019","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2023.100795_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13223-021-00614-6","article-title":"Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis","volume":"17","author":"Meltzer","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2023.100795_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.1316","article-title":"Association between fexofenadine use during pregnancy and fetal outcomes","volume":"174","author":"Andersson","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.waojou.2023.100795_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13223-022-00677-z","article-title":"Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride","volume":"18","author":"Ansotegui","year":"2022","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455123000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455123000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:45:47Z","timestamp":1761849947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455123000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1939455123000558"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2023.100795","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update meta-analysis on the efficacy and safety issues of fexofenadine","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2023.100795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100795"}}